Metroplex Clinical Research Center has successfully completed more than 800 Phase I-IV clinical studies, including more than 300 rheumatoid arthritis studies.
Areas of experience include:
|
Rheumatology
|
Sleep Disorders
|
Migranes
|
|
Rheumatoloid Arthritis
|
Insomnia
|
|
|
Osteoarthritis
|
|
Vaccine
|
|
Osteoporosis
|
Smoking Cessation
|
HIV Vaccine
|
|
Lupus
|
|
Flu Vaccine
|
|
Gout
|
Obesity
|
|
|
Psoriatic Arthritis
|
|
Women's Health
|
|
|
Cardiovascular Disease
|
Osteoperosis
|
|
Dermatology
|
Hypercholosterolemia
|
Bone Density
|
|
|
Hypertension
|
|
The MCRC database contains names of more than 3,000 healthy subjects and more than 20,000 individuals who have participated in clinical research studies or expressed an interest in participation. MCRC staff includes board certified rheumatologists, experienced coordinators, infusion nurses, recruitment specialists, regulatory specialists, and laboratory technicians.
Comprehensive services include:
· Ten physician investigators
· Three physician extenders – two nurse practitioners and one physician’s assistant
· Full-service X-ray department including bone density testing
· Onsite CLIA-certified laboratory
· Onsite infusion unit
MCRC has partnered with the following pharmaceutical sponsors:
Abbott Labrotories
Amgen, Inc.
Biogen, Inc.
Centocor
CombinatoRx
Eli Lilly and Company
Genentech
Hoffman-LaRoche, Inc.
Knoll Pharmaceutical Company
McNeil Consumer Products Company
National Health Institute
NicOx, Inc.
Novatis Pharmaceutical Corporation
Pfizer, Inc.
Proctor & Gamble Pharmaceuticals
Regeneron Pharmaceuticals, Inc.
Roche Global Development
Sanofi Aventis
TAP Pharmaceutical Products
Targeted Genetics Corporation
Trubion Pharmaceuticals, Inc.
Wyeth-Ayerst